New ALS drug enters first human safety testing
Disease control
Recruiting now
This early-stage trial is testing the safety of an experimental drug called siplizumab in 48 adults recently diagnosed with ALS (Lou Gehrig's disease). Researchers will monitor patients for one year to see how their bodies handle the drug and check for side effects. The study wil…
Phase: PHASE1 • Sponsor: ITB-Med LLC • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC